短颈腹主动脉瘤患者中EndoSuture动脉瘤修复与开窗动脉瘤修复的对比
本研究对比短颈腹主动脉瘤患者中EndoSuture动脉瘤修复(ESAR)与开窗腔内动脉瘤修复(FEVAR)的中期结果。倾向性匹配后各18对,ESAR组手术时间和住院时间更短,两组动脉瘤缩小率、Ia型内漏、再干预及动脉瘤相关死亡无显著差异。ESAR似乎是FEVAR在技术受限时的一种现成替代方案。
要点
- ESAR组中位手术时间138分钟 vs FEVAR组240分钟(P < .001)。
- ESAR组中位住院2天 vs FEVAR组7天(P < .001)。
- 两组Ia型内漏、近端瘤颈相关再干预及动脉瘤相关死亡均无观察到。
核心结论
- ESAR似乎是安全的技术,随访期间未观察到主要术后并发症或再干预。
- 在Ia型内漏、动脉瘤缩小和动脉瘤相关死亡率方面,ESAR似乎提供与FEVAR相似的中期结果。
- 在技术受限情况下,ESAR似乎是FEVAR的一种好的现成替代方案。
研究设计与样本
- 所有在2017年9月至2020年5月期间在本中心因短颈腹主动脉瘤接受ESAR的患者被纳入分析。
- 对照组为2012年4月至2020年5月期间因近肾腹主动脉瘤接受FEVAR且符合短颈标准的患者,经术前CT血管造影筛选。
- 按瘤颈长度和瘤颈直径进行倾向性匹配,形成18对匹配。
主要发现
- 中位腹主动脉瘤直径ESAR组54 mm(IQR 52-61 mm) vs FEVAR组58 mm(IQR 53-63 mm),中位瘤颈长度ESAR组8 mm(IQR 6-12 mm) vs FEVAR组10 mm(IQR 6-13 mm)。
- 技术成功率两组均为100%,手术成功率ESAR组94% vs FEVAR组100%。
- 中位手术时间ESAR组138分钟(IQR 113-182分钟) vs FEVAR组240分钟(IQR 199-293分钟)(P < .001),中位住院时间ESAR组2天(IQR 2-3天) vs FEVAR组7天(IQR 6-7天)(P < .001)。
- ESAR组无重大院内并发症,FEVAR组2例(11%)出现重大院内并发症,分别为1例暂时性急性肾损伤和1例暂时性截瘫。
- 中位随访时间ESAR组23个月(IQR 19-33个月) vs FEVAR组36个月(IQR 22-57个月),动脉瘤缩小率ESAR组67% vs FEVAR组61%(P = .73)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to compare midterm results of EndoAnchors in EndoSuture aneurysm repair (ESAR) versus fenestrated endovascular aneurysm repair (FEVAR) in short neck abdominal aortic aneurysm (AAA). METHODS: All patients who underwent an ESAR procedure for a short neck AAA at our center between September 2017 and May 2020 were considered for analysis. To form the control group, preoperative computed tomography angiography of patients who underwent FEVAR for juxtarenal AAA between April 2012 and May 2020 were reviewed and patients who met short neck criteria selected. A propensity-matched score on neck length and neck diameter was calculated, resulting in 18 matched pairs. AAA shrinkage, type Ia endoleaks (EL), AAA-related reinterventions, and AAA-related deaths were compared. RESULTS: The median AAA diameter was 54 mm (interquartile range [IQR], 52-61 mm) versus 58 mm (IQR, 53-63 mm) with a median neck length of 8 mm (IQR, 6-12 mm) vs 10 mm (IQR, 6-13 mm) in ESAR and FEVAR patients, respectively. Technical success was 100% in both groups. Procedural success was 94% in the ESAR group versus 100% in the FEVAR group. The median procedure duration was 138 mm (IQR, 113-182 mm) vs 240 mm (IQR, 199-293 mm) ( P < .001) and the median length of stay was 2 days (IQR, 2-3 days) vs 7 days (IQR, 6-7 days) (P < .001) in ESAR and FEVAR patients, respectively. No major hospital complications were observed in ESAR patients compared with two in FEVAR patients (11%) with one transient acute kidney injury and one transient paraplegia. The median follow-up was 23 months (IQR, 19-33 months) vs 36 months (IQR, 22-57 months) with 67% versus 61% AAA shrinkage in the ESAR and FEVAR groups, respectively (P = .73). No type Ia EL, proximal neck-related reinterventions, or AAA-related deaths were observed in either group. No AAA-related reintervention was observed in the ESAR group versus three reinterventions in the FEVAR group (P = .23). CONCLUSIONS: ESAR seems to be a safe technique with no major postoperative complications or reinterventions observed during follow-up. It seems to offer similar midterm results as FEVAR in terms of type Ia EL, aneurysm shrinkage, and aneurysm-related mortality. ESAR seems to be a good off-the-shelf alternative to FEVAR in case of technical constraints.
引用
- Bordet M, Oliny A, Miasumu T, et al. EndoSuture aneurysm repair versus fenestrated aneurysm repair in patients with short neck abdominal aortic aneurysm. J Vasc Surg. 2022. PMID: 36070845. doi:10.1016/j.jvs.2022.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。